Addressing the Treatment Gap in Pediatric Drug-Resistant Tuberculosis
A new systematic review and individual participant data meta-analysis, published in The Lancet Child & Adolescent Health, provides the largest dataset to date on children and adolescents with multidrug-resistant (MDR) and rifampicin-resistant (RR) tuberculosis globally. Analyzing data from over 23,000 individuals across 42 studies, the research sheds light on critical factors influencing treatment outcomes in this vulnerable population.









